• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Stimulant_Dosing_Thumb.jpg

Stimulant Dosing Limits for ADHD: When Is The Adderall / Ritalin Dose Too High?

September 18, 2024
Chris Aiken, MD., Kelvin Quiñones-Laracuente, MD, PhD, and Greg Malzberg, MD
 In this video, we aim to break down where the safe upper limits lie for stimulant dosing, what to consider when increasing doses, and why crossing certain thresholds can lead to serious risks. We start by discussing why increasing stimulant doses beyond a certain point can be dangerous.
Read More
Methylphenidate_thumb.jpg

L-Methylfolate May Offer Modest Boost to Antidepressants

September 4, 2024
Greg Malzberg, MD and Glen Spielmans, PhD.
In this video, we explore the potential of L-Methylfolate as a vital supplement in depression treatment. L-Methylfolate is a form of folate, a naturally occurring B-vitamin, and is often used to enhance the effects of traditional antidepressants.
Read More
Depression_Augmention_Thumnail.jpg

Personalized Antidepressant Treatments: Augmentation Options for Different Depression Subtypes

August 25, 2024
Deepti Anbarasan, MD., David Liebers, MD, and Greg Malzberg, MD
In this video, we explore the latest breakthroughs in antidepressant augmentation, showing how personalized medicine can enhance outcomes for patients with various forms of depression. Whether your patient is facing anxious depression, depression with insomnia, or psychotic depression, this video offers evidence-based strategies that incorporate augmenation options such as lithium for depression, esketamine for depression, and quetiapine for depression.
Read More
Vilazodone Review Medication Guide.jpg

Vilazodone Review | Mechanism • Faster Onset? • Better for Anxiety? • Sexual Side-effects?

August 14, 2024
Chris Aiken, MD. and Greg Malzberg, MD
Vilazodone, also known by its brand name Viibryd, became available as a generic in June 2022 after 11 years of market exclusivity. With the introduction of the Viibryd generic, the price of this multimodal antidepressant has significantly decreased, making it more accessible. However, the critical question remains: is vilazodone worth prescribing?
Read More
Abilify_Video_thumb.png

Optimal Abilify Dose for Depression (MDD Augmentation with Aripiprazole)

August 13, 2024
Richard Moldawsky, MD and Greg Malzberg, MD

This video breaks down the findings from a meta-analysis of randomized controlled trials, examining how aripiprazole dosage impacts patient outcomes in clinical depression treatment.



Read More
auvthimb.jpg

Auvelity (Dextromethorphan and Bupropion) | A Fast Acting Antidepressant?

August 12, 2024
Chris Aiken, MD. and Greg Malzberg, MD

We’re taking a deep dive into Auvelity, a new antidepressant that combines Dextromethorphan and Bupropion. While Bupropion is well-established in the treatment of depression, Dextromethorphan is less familiar in psychiatric contexts.


Read More
Screenshot 2024-08-13 at 4.19.27 PM.png

An Off-Label Guide to Gabapentin | Anxiety, Sleep, Addiction, Pain, & More

August 8, 2024
Greg Malzberg, MD, Chris Aiken, MD, and Rajesh R. Tampi, MD, MS, DFAPA.
In today’s video, we explore the off-label uses of Gabapentin, also known as Neurontin. While Gabapentin is FDA-approved for partial seizures and postherpetic neuralgia, its off-label uses are more extensive, especially in psychiatry.
Read More
WriteForUs.png

Join Our Writing Team

July 18, 2024
DEA_Checkbox.png

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Satisfy the DEA requirement for 8 hours of training in opioid or other substance use disorders
May 24, 2024
shutterstock_2417738561_PeopleImages.com_Yuri A.png
COMMENTARY

Insights About a Rare Transmissible Form of Alzheimer's Disease

February 9, 2024
Rehan Aziz, MD

Researchers found a connection between Alzheimer's disease and the use of contaminated growth hormone from human cadavers, highlighting the importance of understanding Alzheimer's pathology for better treatment development.



Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.